vTv Therapeutics (VTVT)
Develops oral small molecules for diabetes, centered on cadisegliatin alongside insulin.
$33.61
At close+1.66 (+5.20%)
Something off on this page? Send us feedback.
Next report
Nov 5, 2026
estimated · in 63 days
EPS estimate
−$1.16
Revenue estimate
$333.3K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.55−$0.77−$0.92−$1.08−$0.58$1.65−$1.05Pending
Estimate−$0.87−$0.73−$0.85−$0.97−$0.98$0.34−$0.97−$1.16
Surprise+36.8%−5.5%−8.2%−11.3%+40.8%+385.3%−8.2%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$17.0K————$36.8M—Pending
Estimate—————$20.0M$333.3K$333.3K
Surprise—————+84.2%——
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.16 | — | — |
| Aug 2026 | −$0.97 | −$1.05 | −8.2% |
| May 2026 | $0.34 | $1.65 | +385.3% |
| Mar 2026 | −$0.98 | −$0.58 | +40.8% |
| Nov 2025 | −$0.97 | −$1.08 | −11.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Sep 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$1.16 | — | — | $333.3K | — | — | — |
| Aug 6, 2026 | −$0.97 | −$1.05 | −8.2% | $333.3K | — | — | +0.6% |
| May 13, 2026 | $0.34 | $1.65 | +385.3% | $20.0M | $36.8M | +84.2% | +21.4% |
| Mar 10, 2026 | −$0.98 | −$0.58 | +40.8% | — | — | — | +0.2% |
| Nov 6, 2025 | −$0.97 | −$1.08 | −11.3% | — | — | — | +2.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 12, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 20, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 13, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 11, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 6, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 29, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 4, 2021 | |||||||
| May 5, 2021 | |||||||
| Feb 24, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 3, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 20, 2020 | |||||||
| Oct 30, 2019 | |||||||
| Jul 31, 2019 | |||||||
| May 1, 2019 | |||||||
| Feb 27, 2019 | |||||||
| Nov 8, 2018 | |||||||
| Aug 3, 2018 | |||||||
| May 15, 2018 | |||||||
| Feb 27, 2018 | |||||||
| Nov 1, 2017 | |||||||
| Aug 2, 2017 | |||||||
| May 3, 2017 | |||||||
| Feb 27, 2017 | |||||||
| Nov 2, 2016 | |||||||
| Aug 2, 2016 | |||||||
| May 12, 2016 | |||||||
| Mar 1, 2016 | |||||||
| Nov 12, 2015 | |||||||
| Sep 14, 2015 | |||||||